Little is known about the association between inflammatory biomarkers, such as interleukin‐6 (IL‐6) and C‐reactive protein (CRP) in the acute phase, and persistent symptoms after hospitalization in COVID‐19 patients. This evidence concerns the gene CRP and COVID-19.